WASHINGTON (MedPage Today) -- The FDA has approved a 13-valent version of the pneumococcal conjugate vaccine Prevnar for use in pediatric patients 6 months to 5 years old.
pneumococcal conjugate vaccineNew Version of Pneumococcal Vaccine Gets OkayMedPage Today Infectious Disease Wed, 02/24/2010 - 13:05
Short Vaccine Course Reduces Pneumococcal Carriage (CME/CE)MedPage Today Infectious Disease Wed, 07/08/2009 - 07:02
TORONTO (MedPage Today) -- A short course of the pneumococcal conjugate vaccine significantly reduces carriage of Streptococcus pneumoniae in the nasal passages of treated children, Dutch researchers said. Tags:
|
